May 13 |
Research Solutions, Inc. (NASDAQ:RSSS) Q3 2024 Earnings Call Transcript
|
Apr 15 |
Research Solutions Unveils AI Platform for Automated Clinical Trial Landscape Reports
|
Apr 6 |
With 37% stake, Research Solutions, Inc. (NASDAQ:RSSS) seems to have captured institutional investors' interest
|
Mar 7 |
Artko Capital - Research Solutions: A Tumultuous Year But Outlook And Growth Look Excellent
|
Feb 15 |
Research Solutions Launches AI Platform to Automatically Create Technology Landscape Reports
|
Feb 9 |
Research Solutions, Inc. (NASDAQ:RSSS) Q2 2024 Earnings Call Transcript
|
Feb 9 |
Research Solutions, Inc. (RSSS) Q2 2024 Earnings Call Transcript
|
Feb 8 |
Research Solutions GAAP EPS of $0.00 beats by $0.03, revenue of $10.3M beats by $0.51M
|
Feb 8 |
Research Solutions Reports Fiscal Second Quarter 2024 Results
|
Jan 18 |
Investing in Research Solutions (NASDAQ:RSSS) a year ago would have delivered you a 28% gain
|